Evommune, Inc. (EVMN) Tops Q1 EPS by 12c

Evommune, Inc. (NYSE: EVMN) reported Q1 EPS of ($0.64), $0.12 better than the analyst estimate of ($0.76).

For earnings history and earnings-related data on Evommune, Inc. (EVMN) click here.

You May Also Be Interested In

• Robinhood Ventures Fund II opens at $22.50, IPO at $25
• Omega Flex (OFLX) Tops Q2 EPS by 27c
• Sandisk targets mid-to-high teens revenue growth through FY2030